Literature DB >> 30478165

Emergence of Resistance to Quinolones and β-Lactam Antibiotics in Enteroaggregative and Enterotoxigenic Escherichia coli Causing Traveler's Diarrhea.

Elisabet Guiral1, Milene Gonçalves Quiles1, Laura Muñoz1, Javier Moreno-Morales1, Izaskun Alejo-Cancho2, Pilar Salvador2, Miriam J Alvarez-Martinez1,2, Francesc Marco1,2, Jordi Vila3,2.   

Abstract

The objective of this study was to assess the antimicrobial resistance of enteroaggregative Escherichia coli (EAEC) and enterotoxigenic E. coli (ETEC) strains causing traveler's diarrhea (TD) and to investigate the molecular characterization of antimicrobial resistance genes to third-generation cephalosporins, cephamycins, and quinolones. Overall, 39 EAEC and 43 ETEC clinical isolates were studied. The susceptibilities of EAEC and ETEC against ampicillin, amoxicillin-clavulanic acid, cefotaxime, imipenem, chloramphenicol, tetracycline, co-trimoxazole, nalidixic acid, ciprofloxacin, azithromycin, and rifaximin were determined. All genes encoding resistance determinants were detected by PCR or PCR plus DNA sequencing. The epidemiology of selected EAEC and ETEC strains was studied using multilocus sequence typing (MLST). The resistance to quinolones of EAEC and ETEC strains causing TD has significantly increased over the last decades, and high percentages have been found especially in patients traveling to India and sub-Saharan Africa. Sequence type 38 (ST38) and ST131, carrying the bla CTX-M-15 and bla CTX-M-27 genes, respectively, are highly prevalent among extended-spectrum β-lactamase (ESBL)-producing EAEC and ETEC strains. The cephamycinase ACT-20 is described in the present study for the first time in EAEC and ETEC strains causing TD in patients who had traveled to Central America. The percentages of resistance to azithromycin in EAEC and ETEC isolates from patients to Southeast Asia/India and Africa are above 25%. Meanwhile, rifaximin is still active against EAEC and ETEC, with the prevalence of resistant strains not being high. In conclusion, fluoroquinolones should no longer be considered the drugs of choice for the prevention or treatment in TD for travelers traveling to India and Africa. Azithromycin and rifaximin are still a good alternative to treat TD caused by EAEC or ETEC.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  cephalosporin; enteroaggregative E. colizzm321990; enterotoxigenic E. colizzm321990; quinolones; resistance; traveler’s diarrhea

Mesh:

Substances:

Year:  2019        PMID: 30478165      PMCID: PMC6355616          DOI: 10.1128/AAC.01745-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  60 in total

1.  Multiplex PCR scheme for variant plasmid mediated class C β-lactamase typing.

Authors:  Le Van Chuong; Virapong Prachayasittikul; Chartchalerm Isarankura Na Ayudhya; Ratana Lawung
Journal:  J Clin Lab Anal       Date:  2017-07-18       Impact factor: 2.352

2.  Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern.

Authors:  Mohammad Mehdi Aslani; Mohammad Yousef Alikhani; Ali Zavari; Rasol Yousefi; Ali Reza Zamani
Journal:  Int J Infect Dis       Date:  2010-12-03       Impact factor: 3.623

3.  Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.

Authors:  J Vila; J Ruiz; P Goñi; M T De Anta
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 4.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.

Authors:  Vincent Cattoir; Laurent Poirel; Vincent Rotimi; Claude-James Soussy; Patrice Nordmann
Journal:  J Antimicrob Chemother       Date:  2007-06-08       Impact factor: 5.790

Review 6.  The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world.

Authors:  Yohei Doi; Alina Iovleva; Robert A Bonomo
Journal:  J Travel Med       Date:  2017-04-01       Impact factor: 8.490

7.  Replicon typing of plasmids encoding resistance to newer beta-lactams.

Authors:  Alessandra Carattoli; Vivi Miriagou; Alessia Bertini; Alexandra Loli; Celine Colinon; Laura Villa; Jean M Whichard; Gian Maria Rossolini
Journal:  Emerg Infect Dis       Date:  2006-07       Impact factor: 6.883

8.  Evidence of evolving extraintestinal enteroaggregative Escherichia coli ST38 clone.

Authors:  Marie Anne Chattaway; Claire Jenkins; Holly Ciesielczuk; Martin Day; Vivienne DoNascimento; Michaela Day; Irene Rodríguez; Alieda van Essen-Zandbergen; Anne-Kathrin Schink; Guanghui Wu; John Threlfall; Martin J Woodward; Nick Coldham; Kristina Kadlec; Stefan Schwarz; Cindy Dierikx; Beatriz Guerra; Reiner Helmuth; Dik Mevius; Neil Woodford; John Wain
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

9.  Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

Authors:  Teresa M Coque; Angela Novais; Alessandra Carattoli; Laurent Poirel; Johann Pitout; Luísa Peixe; Fernando Baquero; Rafael Cantón; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) among travellers to Africa: destination-specific data pooled from three European prospective studies.

Authors:  Tinja Lääveri; Jessica A Vlot; Alje P van Dam; Hanni K Häkkinen; Gerard J B Sonder; Leo G Visser; Anu Kantele
Journal:  BMC Infect Dis       Date:  2018-07-23       Impact factor: 3.090

View more
  11 in total

Review 1.  Acute Bacterial Gastroenteritis.

Authors:  James M Fleckenstein; F Matthew Kuhlmann; Alaullah Sheikh
Journal:  Gastroenterol Clin North Am       Date:  2021-04-23       Impact factor: 3.806

2.  Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply.

Authors:  Robert Steffen; Herbert L DuPont
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

3.  Phenotypic and genotypic characterization of multi-drug-resistant Escherichia coli isolates harboring blaCTX-M group extended-spectrum β-lactamases recovered from pediatric patients in Shenzhen, southern China.

Authors:  Sandip Patil; Xiaowen Chen; Ma Lian; Feiqiu Wen
Journal:  Infect Drug Resist       Date:  2019-05-16       Impact factor: 4.003

4.  Two putative MmpL homologs contribute to antimicrobial resistance and nephropathy of enterohemorrhagic E. coli O157:H7.

Authors:  Salma H Hussein; Reham Samir; Ramy K Aziz; Mohamed A Toama
Journal:  Gut Pathog       Date:  2019-04-18       Impact factor: 4.181

5.  Antimicrobial Efficacy of Indolicidin Against Multi-Drug Resistant Enteroaggregative Escherichia coli in a Galleria mellonella Model.

Authors:  Jess Vergis; Satyaveer Singh Malik; Richa Pathak; Manesh Kumar; Sunitha Ramanjaneya; Nitin Vasantrao Kurkure; Sukhadeo Baliram Barbuddhe; Deepak Bhiwa Rawool
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

6.  Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection.

Authors:  Rebecca Lester; Hendran Maheswaran; Christopher P Jewell; David G Lalloo; Nicholas A Feasey
Journal:  Wellcome Open Res       Date:  2020-06-01

Review 7.  Insights into Emergence of Antibiotic Resistance in Acid-Adapted Enterohaemorrhagic Escherichia coli.

Authors:  Salma Waheed Sheikh; Ahmad Ali; Asma Ahsan; Sidra Shakoor; Fei Shang; Ting Xue
Journal:  Antibiotics (Basel)       Date:  2021-05-02

8.  F Plasmids Are the Major Carriers of Antibiotic Resistance Genes in Human-Associated Commensal Escherichia coli.

Authors:  Craig Stephens; Tyler Arismendi; Megan Wright; Austin Hartman; Andres Gonzalez; Matthew Gill; Mark Pandori; David Hess
Journal:  mSphere       Date:  2020-08-05       Impact factor: 4.389

9.  Enteroaggregative E. coli Adherence to Human Heparan Sulfate Proteoglycans Drives Segment and Host Specific Responses to Infection.

Authors:  Anubama Rajan; Matthew J Robertson; Hannah E Carter; Nina M Poole; Justin R Clark; Sabrina I Green; Zachary K Criss; Boyang Zhao; Umesh Karandikar; Yikun Xing; Mar Margalef-Català; Nikhil Jain; Reid L Wilson; Fan Bai; Joseph M Hyser; Joseph Petrosino; Noah F Shroyer; Sarah E Blutt; Cristian Coarfa; Xuezheng Song; Bv Venkataram Prasad; Manuel R Amieva; Jane Grande-Allen; Mary K Estes; Pablo C Okhuysen; Anthony W Maresso
Journal:  PLoS Pathog       Date:  2020-09-28       Impact factor: 6.823

Review 10.  Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli-prospective traveller study with literature review.

Authors:  Anu Kantele; Tinja Lääveri
Journal:  J Travel Med       Date:  2022-01-17       Impact factor: 8.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.